News from the year 2021

InflaRx, a bm|t Investee-Partner, completed a minimum 75 Mio. USD equity raise, greatly enhancing the company’s ability to continue advancing its promising pipeline through multiple significant milestones.

InflaRx N.V. (Nas­daq: IFRX), a clin­i­­cal-stage bio­phar­ma­ceu­ti­cal com­pany devel­op­ing anti-inflam­­ma­­tory ther­a­peu­tics by tar­get­ing the com­ple­ment sys­tem, announced today that it has com­pleted its under­writ­ten public

read more »
Alle Jahrgänge